Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
24 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

PCRX — Pacira BioSciences, Inc. Dilution Risk Tracker

Track PCRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PCRX — Get alerts when the score changes →

As of August 28, 2026, Pacira BioSciences, Inc. (PCRX) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Pacira BioSciences, Inc. has a market capitalization of $913.66M, 39.86M shares outstanding, 243 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
37
💰Cash Runway
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PCRX.
🔔 Track PCRX — Get forecast alerts →

Market Data

Market Cap$913.66M
Shares Outstanding39.86M
Float33.67M
Cash$251.03M
Debt$363.12M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.4% shares (2026Q1 vs prior)
243 institutional holders · 51.63M shares
#1 BlackRock, Inc. 6.74M shares
#2 MORGAN STANLEY 3.73M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.57M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.21M
Days to Cover13.4
% of Float21.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PCRX Dilution Snapshot

Pacira BioSciences, Inc. (PCRX) has a DilutionScore of 24/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PCRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PCRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for PCRX
PCRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.